# Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P

> **NCT03369340** · NA · COMPLETED · sponsor: **Philip Morris Products S.A.** · enrollment: 19 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **OTHER:** P3P 1
- **OTHER:** P3P 2
- **OTHER:** P3P 3
- **OTHER:** P3P 4

## Key facts

- **NCT ID:** NCT03369340
- **Lead sponsor:** Philip Morris Products S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-07
- **Primary completion:** 2018-02-01
- **Final completion:** 2018-05-02
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03369340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03369340, "Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03369340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*